1[1]Waagstein F,Hjalmarson A,Varnauskas E,et al.Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.B Heart J,1975,37:1022～1036.
2[2]MERIT-HF study group.Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF).Lancet,1999,353:2001～2007.
3[3]CIBIS Ⅱ investigators and committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS Ⅱ):a randomised trial.Lancet,1999,353:9～13.
4[4]Bristow MR.Mechanism of action of beta-blocking agents in heart failure.Am J Cardiol,1997,80:L26～L40.
5[5]Australia/New Zealand Heart failure Research Collaborative Group. Randomised placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease.Lancet,1997,349:375～380.
7[7]Dargie HJ.Effect of carvedilol in outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.Lancet,2001,357: 1385～1390.
8[8]Lechat PP,Packer M,Chalon S,et al.Clinic effects of β-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind ,placebo-controlled,randomized trials.Circulation,1998,98:1184～1191.
9[9]Macdonald PS,Keogh AM,Aboyoun CL,et al. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.Cardiol,1999,33:924～931.
10[10]Yancy CW,Fowler MB,Colucci WS,et al.Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.N Engl J Med,2001,344:1358～1365.
